You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
Galcanezumab in episodic migraine: subgroup analyses of efficacy by high versus low frequency of migraine headaches in phase 3 studies (EVOLVE-1 & EVOLVE-2)
|
---|---|
Published in |
The Journal of Headache and Pain, June 2019
|
DOI | 10.1186/s10194-019-1024-x |
Pubmed ID | |
Authors |
Stephen D. Silberstein, Virginia L. Stauffer, Katie A. Day, Sarah Lipsius, Maria-Carmen Wilson |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Hungary | 1 | 33% |
United Kingdom | 1 | 33% |
Unknown | 1 | 33% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 67% |
Scientists | 1 | 33% |
Mendeley readers
The data shown below were compiled from readership statistics for 105 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 105 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 14 | 13% |
Other | 8 | 8% |
Student > Bachelor | 8 | 8% |
Student > Ph. D. Student | 7 | 7% |
Student > Doctoral Student | 5 | 5% |
Other | 15 | 14% |
Unknown | 48 | 46% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 29 | 28% |
Neuroscience | 8 | 8% |
Pharmacology, Toxicology and Pharmaceutical Science | 6 | 6% |
Psychology | 6 | 6% |
Nursing and Health Professions | 3 | 3% |
Other | 4 | 4% |
Unknown | 49 | 47% |
Attention Score in Context
This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 February 2022.
All research outputs
#6,212,119
of 23,849,058 outputs
Outputs from The Journal of Headache and Pain
#575
of 1,417 outputs
Outputs of similar age
#108,392
of 352,457 outputs
Outputs of similar age from The Journal of Headache and Pain
#20
of 33 outputs
Altmetric has tracked 23,849,058 research outputs across all sources so far. This one has received more attention than most of these and is in the 73rd percentile.
So far Altmetric has tracked 1,417 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 17.6. This one has gotten more attention than average, scoring higher than 59% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 352,457 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 68% of its contemporaries.
We're also able to compare this research output to 33 others from the same source and published within six weeks on either side of this one. This one is in the 39th percentile – i.e., 39% of its contemporaries scored the same or lower than it.